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Abstract
We identified different lipemic and metabolic responses after the ingestion of a standardized meal by healthy adults and related 
them to atherosclerotic markers. Samples from 60 normolipidemic adults were collected before and after a liquid meal (40 g 
fat/m2 body surface) at 0, 2, 4, 6, and 8 h for measurements of lipids, free fatty acids (FFA), insulin, cholesteryl ester transfer 
protein (CETP), autoantibodies to epitopes of oxidized LDL (oxLDL Ab), lipolytic activities, and apolipoprotein E polymorphism. 
Mean carotid intima-media thickness (cIMT) was determined by Doppler ultrasound. The volunteers were classified into early 
(N = 39) and late (N = 31) triacylglycerol (TAG) responders to the test meal. Late responders showed lower HDL cholesterol 
concentration at fasting and in the TAG peak, lower insulin and higher FFA concentrations compared to early responders. Mul-
tivariate regression analyses showed that mean cIMT was associated with gender (male) and age in early responders and by 
cholesterol levels at the 6th hour in late responders. oxLDL Ab were explained by lipoprotein lipase and negatively by hepatic 
lipase and oxLDL Ab (fasting period) by CETP (negative) and FFA (positive). This study is the first to identify a postalimentary 
insulin resistance state, combined with a reduced CETP response exclusively among late responders, and the identification of 
the regulators of postalimentary atherogenicity. Further research is required to determine the metabolic mechanisms described 
in the different postalimentary phenotypes observed in this study, as well as in different pathological states, as currently inves-
tigated in our laboratory.
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Hypertriglyceridemia has been implicated in the risk of 
atherosclerosis-related cardiovascular events (1). Evidence 
from meta-analysis of a number of clinical studies in a large 
number of patients has established the increased concen-
tration of plasma triacylglycerol (TAG) as an independent 
risk factor for coronary heart disease (CHD) (2). It is known 
that elevated fasting serum TAG concentration is a marker 
for atherogenic remnant lipoproteins and apolipoprotein B-
containing lipoproteins or for other lipids and non-lipid risk 
factors (3). Epidemiologic data indicate that non-fasting TAG 
levels also are significantly associated with cardiovascular 
event rates (4,5). The finding of TAG-rich lipoproteins in hu-
man atheroma has provided substantial pathophysiologic 
indication of their direct role in atherogenesis (6). TAG-
rich lipoproteins are able to penetrate the arterial wall and 
reach the subendothelial space causing endothelial lipid 
deposits, attraction of monocytes, production of inflam-
matory markers, and oxidative stress. The role of TAG in 
the atherosclerosis-mediated inflammation depends not 
only on their direct effect on the endothelium, but also on 
attenuating the protective effects of high-density lipoprotein 
(HDL) against vascular inflammation (7). 
Postalimentary lipemia was first described as an 
atherogenic phenomenon by Zilversmit in 1979 (8). Later, 
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it received more attention after the discovery that TAG-rich 
lipoproteins are atherogenic (9) and that patients with es-
tablished CHD also have postprandial abnormalities in TAG 
metabolism, such as elevated concentrations and prolonged 
postprandial response after a fatty meal (10). 
In Western societies, people spend most of their days 
in the postalimentary state because they have sequential 
eating habits. The magnitude of lipemia and of TAG peaks, 
the number of peaks, the time from baseline values to initial 
response, the lag time to peak, and the time to return to 
baseline values vary among individuals and are important 
components of the atherogenicity of the postalimentary 
state (11,12). The studies found in the literature have not 
explored the metabolic background involved in the lipemic 
responses. 
Clinical studies have shown an independent relationship 
between lipemia and early atherosclerosis as shown by the 
carotid intima-media thickness (cIMT) correlation with TAG 
at 1 to 4 h (11) or at 6 and 7 h (12). Moreover, patients with 
established coronary atherosclerosis present elevated TAG 
concentrations in the postalimentary state (12). Thus, the 
ultrasonic cIMT procedure can be used as an atheroscle-
rosis marker to assess sub-clinical stages of the disease 
and predict coronary atherosclerosis (13). 
Autoantibodies to epitopes of oxidized low-density 
lipoprotein (oxLDL Ab) are reported to play important roles 
in atherosclerosis, which monitor the degree of oxidative 
changes in LDL (14). These antibodies have been found in 
human plasma, as well as in human atherosclerotic lesions 
and in laboratory animals. 
The objective of the present study was to measure the 
lipemic responses to a fat meal, metabolic components as-
sociated with it such as free fatty acids (FFA), insulin and 
cholesteryl ester transfer protein (CETP), and to determine 
their relationships with atherosclerosis biomarkers such as 
titers of oxLDL Ab and mean cIMT. To address this topic, 
we examined the postalimentary TAG responses of 60 
normolipidemic asymptomatic adults.
Material and Methods
Experimental protocol
Sixty volunteers, 29 women (48%) and 31 men (52%), 
aged 18 to 45 years were selected for this study using 
the following criteria: all clinically asymptomatic, without 
any established CHD or cardiovascular risk factors such 
as the presence of dyslipidemia, hypertension, smoking, 
family history of myocardial infarction or sudden death, and 
diabetes mellitus, according to the recommendations of the 
National Cholesterol Education Program (15). 
The protocol was approved by the Ethics Committee of 
the Faculdade de Ciências Médicas, Universidade Estadual 
de Campinas, São Paulo State. All participants gave written 
informed consent. 
After an overnight fast (hereafter called baseline or 
fasting period, FP), blood was drawn into tubes containing 
1 mg/mL EDTA. The volunteers received a lactose-free 
milkshake liquid meal (57% carbohydrate, 13% protein, 
25% fat, 9.8 g% saturated fat, 4 g% linoleic acid, 0.5 g% 
linolenic acid, and 10 mg cholesterol), providing 40 g fat/
m2 body surface (estimated from height and weight) over 
a period of up to 10 min (approximately 350 mL). Addi-
tional blood samples were collected after 2, 4, 6, and 8 h, 
hereafter called postalimentary period. Insulin, CETP and 
oxLDL Ab were measured during fasting and in the TAG 
peak period (highest TAG concentration after the meal). 
Lipoprotein lipase (LPL) and hepatic lipase (HL) activities 
were analyzed only during the fasting period. The other 
parameters were measured at all times.
After 2 to 3 days, the participants returned for a second 
visit to have fasting plasma collected for the quantification 
of lipases, 15 min after an intravenous heparin injection 
(100 U/kg body weight); up to 6 days after the first visit 
they came for a third visit for ultrasonographic examination 
of the carotid. 
Analytical methods
Cholesterol, TAG and glucose were determined using 
enzymatic colorimetric methods and plasma HDL and LDL 
cholesterol were determined by homogeneous enzymatic 
colorimetric assays, all provided by Roche Diagnostics 
(Switzerland). 
FFA were measured by an enzymatic method (Waco, 
Japan) and insulin by an immunometric assay (Immulite/
DPC/Medlab, USA).
LPL and HL activities were measured in post-heparin 
plasma samples on the basis of fatty acid release, using a 
radiolabeled triolein emulsion as the substrate and NaCl 
(1 M) as the LPL inhibitor (16). 
CETP activity was determined by an exogenous as-
say that measures the transfer of radiolabeled cholesteryl 
ester between a normal donor pool of 14CE-HDL and an 
unlabeled acceptor mixture of very LDL (VLDL) plus LDL 
over 4 h, using plasma as the CETP source (17), and the 
results are reported as percent cholesteryl ester transferred. 
The inter-assay coefficients of variation were 11, 15, and 
12% for CETP, LPL, and HL, respectively.
The chemical modification of LDL generates a variety 
of modified lipids and proteins that represent highly im-
munogenic neo-determinants. The IgG antibodies against 
holo-oxidized LDL were evaluated by ELISA after samples 
were incubated with copper-oxidized LDL (18). The results 
are presented as percent absorbance readings relative to 
the group ranked values. 
Genomic DNA was obtained from peripheral blood 
cells by conventional methods (19). Restriction analysis 
of the PCR-amplified apolipoprotein E genotypes (ApoE 
gene) polymorphism was performed as previously reported 
(20). 
High-resolution B-mode carotid ultrasonography was 
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performed by a single trained sonographer, who was 
blind to the subject’s identity, using a 6-9-MHz linear ar-
ray ultrasound imaging system (ATL HDI 1500 and 3500 
Ultrasound System, Advanced Technology Laboratories 
Ultrasound, USA). The far wall of the distal 1 cm of the left 
and right common carotid arteries was scanned according 
to a standardized method (21). The mean common carotid 
intima-media thickness was calculated as the average of five 
measurements on each side (right and left) and expressed 
in mm. The individual results were reported as the average 
of the left and right cIMT in mm. 
Statistical analyses
The statistical analyses were performed using visual 
inspection of the curves and the SPSS statistical package 
6.0 (SPSS Inc., USA). The areas under the curves (AUC) 
and areas under the incremental curves (AUIC) were mea-
sured by the trapezoidal rule. Average differences were 
determined by one-way ANOVA followed by the post hoc 
Duncan test or the chi-square test, and the Wilcoxon test 
was used for comparison of fasting and postalimentary pe-
riods. Univariate and multivariate regression analyses were 
performed with the SAS for Windows software (Statistical 
Analysis System), 9.1.3, to understand which parameters 
were associated with mean cIMT, FP oxLDL Ab and TAG 
peak oxLDL Ab in the early and late groups, 
using stepwise criteria for variable selection 
and transforming the numerical variables into 
ranks in the absence of normal distribution. 
Female gender was used as reference.
The independent variables used in the 
multivariate analyses were: age, gender, 
body mass index (BMI), weight, systolic 
blood pressure, diastolic blood pressure, 
mean cIMT, cholesterol (FP, 2-8 h, AUC and 
AUIC), TAG (FP, 2-8 h, AUC and AUIC), HDL 
cholesterol (FP, 2-8 h, AUC and AUIC), LDL 
cholesterol (FP, 2-8 h, AUC and AUIC), VLDL 
cholesterol (FP, 2-8 h, AUC and AUIC), FFA 
(FP, 2-8 h, AUC and AUIC), insulin (FP and 
4 h), CETP (FP and 4 h), FP PLTP, FP HL, 
FP LPL, oxLDL Ab, and TAG peak oxLDL 
Ab. Biphasic and late groups were pooled 
to reach statistical power.
The tests were considered to be sig-
nificant at the probability value (P) of 0.05 
or less. 
Results
Three groups were observed after the 
graphic characterization of the responders 
as early (65%, N = 39), late (35%, N = 21) 
and biphasic (N = 10) responders. Half of the 
late responders were biphasic responders. 
Early responders were defined as: time to TAG peaks at the 
2nd to 4th hour, initial response at the 2nd and 4th hours, 
back to baseline at the 6th to 8th hour; late responders as: 
time to TAG peaks at the 6th to 8th hour, initial response 
at the 2nd to 6th hour and back to baseline, later than in 
the 8th hour, and biphasic responders as: 1st peak at the 
2nd hour and the 2nd peak at the 6th hour.
In the early group, TAG was higher at the 4th hour 
and lower at the 6th and 8th hours when compared to 
late responders. FP TAG and the 2nd-hour responses, as 
well as peak TAG concentrations, were similar among all 
groups (Figure 1A). 
The early responders showed increased TAG from 
baseline to the 2nd, 4th, and 6th hours; the late and biphasic 
responders showed increased TAG from baseline to the 
2nd, 4th, 6th, and 8th hours (Figure 1A). There were no 
differences in the magnitude of postalimentary lipemia as 
measured by the TAG AUCs and AUICs (Figure 1B). 
Table 1 shows the similarity of the anthropometric and 
biochemical characteristics of the participants. No differ-
ences were found among the three phenotypes for age, 
gender, BMI, waist circumference, blood pressure, mean 
cIMT, TAG, cholesterol, LDL cholesterol, CETP activity, 
and oxLDL Ab in fasting and TAG peak and only in fast-
ing FFA, HL activity, glucose, and insulin. However, the 
Figure 1. Plasma triacylglycerol (TAG) response groups and triacylglycerol areas 
under the curves (AUC) and areas under the incremental curves (AUIC) after a 
standardized fat meal. Data are reported as means ± SEM. Number of subjects 
per group: early responders = 39; late responders = 21; biphasic responders = 10. 
Wilcoxon test. A, TAG response groups: during the fasting period (FP, 0 h), 2, 4, 
6, and 8 h by group; all individuals (N = 60): 1P ≤ 0.0002, TAG increased from FP 
to 2, 4, 6, and 8 h; early responders: 2P ≤ 0.00001, TAG increased from fasting to 
2, to 4 and to 6 h; late responders: 3P ≤ 0.0033, TAG increased from FP to 2, 4, 6, 
and 8 h; biphasic responders: 4P ≤ 0.017, TAG increased from FP to 2, 4, 6, and 
8 h. TAG during fasting, at 2 h and at peaks among groups were not significant; 
5P ≤ 0.0169, TAG at 4 h, higher in early than in late and biphasic responders; 6P 
≤ 0.045, TAG at 6 h, lower in early than in late responders; 7P ≤ 0.0022, TAG at 
8 h, lower in early than in late and biphasic responders (ANOVA followed by the 
post hoc Duncan test). B, TAG AUC and AUIC by group (mg·dL-1·h-1). Results not 
significant among groups.
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groups were quite diverse metabolically in the fasting and 
postalimentary periods. 
FP and TAG peak HDL cholesterol were 15 and 17% 
lower in late and biphasic responders, respectively, than in 
early responders; FFA in TAG peak was 33% lower in the 
early group than in the late and biphasic responders. FFA 
was higher in the late and biphasic responders. FP LPL 
was 21 and 30% lower in early than in late and biphasic 
responders, respectively. Insulin in the TAG peak period 
was 74 and 79% lower in the late and biphasic groups as 
compared to the early groups (Table 1). 
Figure 2A presents postalimentary data about FFA, in-
sulin and CETP for all participants and in the three groups. 
In early responders, FFA increased from baseline to the 8th 
hour after the meal and in late responders it decreased from 
baseline to the 2nd and the 4th hours and then increased 
up to the 8th hour. 
All phenotypes increased their insulin concentrations 
up to their TAG peaks after the meal (Figure 2B). The 
expected insulin peak would have been in the first 2 h of 
the postalimentary period, but the measurements were not 
determined at this time point. 
Table 1. Anthropometric and biochemical characteristics of the participants during the fasting and 
postalimentary periods.
Parameters Groups
All (N = 60) Early (N = 39) Late (N = 21) Biphasic (N = 10)
Age (years) 29 ± 8 30 ± 7 28 ± 8 27 ± 8
Gender (female/male) 29/31 21/18 8/13 3/7
Body mass index (kg/m2) 22 ± 2 23 ± 2 22 ± 2 23 ± 2
Waist circumference (cm) 74 ± 6 75 ± 6 73 ± 7 74 ± 6
Systolic blood pressure (mmHg) 115 ± 10 113 ± 10 117 ± 9 120 ± 11
Diastolic blood pressure (mmHg) 75 ± 8 74 ± 8 76 ± 8 78 ± 8
Mean cIMT (mm) 0.58 ± 0.06 0.57 ± 0.06 0.57 ± 0.06 0.55 ± 0.04
FP TAG (mg/dL) 72 ± 31 70 ± 29 75 ± 35 75 ± 36
TAG peak (mg/dL) 150 ± 64 153 ± 66 146 ± 61 150 ± 61
FP cholesterol (mg/dL) 156 ± 29 160 ± 29 150 ± 29 152 ± 20
TAG peak cholesterol (mg/dL) 155 ± 30 158 ± 29 149 ± 30 150 ± 20
FP LDL-C (mg/dL) 95 ± 23 96 ± 22 91 ± 24 94 ± 20
TAG peak LDL-C (mg/dL) 84 ± 21 86 ± 20 81 ± 22 82 ± 16
FP HDL-C (mg/dL) 49 ± 11 52 ± 11 44 ± 9* 43 ± 8*
TAG peak HDL-C (mg/dL) 47 ± 12 50 ± 12 43 ± 9* 43 ± 9*
FP FFA (mM) 0.7 ± 0.3 0.7 ± 0.3 0.7 ± 0.4 0.7 ± 0.5
TAG peak FFA (mM) 0.7 ± 0.3 0.6 ± 0.2 0.9 ± 0.4* 0.9 ± 0.5*
FP LPL (nmol FFA·mL-1·h-1) 2303 ± 792 2114 ± 789 2667 ± 682* 3010 ± 565*
FP HL (nmol FFA·mL-1·h-1) 2861 ± 1284 2889 ± 1211 2808 ± 1457 3249 ± 1445
FP CETP (%) 17 ± 6 17 ± 7 19 ± 6 19 ± 4
TAG peak CETP (%) 22 ± 8 22 ± 8 22 ± 8 22 ± 9
FP glucose (mg/dL) 84 ± 8 85 ± 8 83 ± 7 84 ± 8
FP insulin (µIU/mL) 3.5 ± 1.9 3.8 ± 2.1 2.8 ± 1.4 2.4 ± 0.4
TAG peak insulin (µIU/mL) 29 ± 26 39 ± 27 10 ± 9* 8 ± 6*
FP oxLDL Ab (%) 42 ± 24 41 ± 25 44 ± 24 46 ± 26
TAG peak oxLDL Ab (%) 51 ± 25 52 ± 25 48 ± 25 39 ± 15
Data are reported as means ± SD. N = number of subjects with parameters determined. Early group = time 
to TAG peaks at the 2nd to 4th hour, initial response at the 2nd and 4th hours, back to baseline at the 6th to 
8th hour. Late group = time to TAG peaks at the 6th to 8th hour, initial response at the 2nd to 6th hour and 
back to baseline later than in the 8th hour. Biphasic group = 1st peak at the 2nd hour and the 2nd peak at 
the 6th hour. cIMT = carotid intima-media thickness; TAG = triacylglycerol; FP = fasting period; TAG peak 
= time of the highest triacylglycerol concentration; LDL-C and HDL-C = low- and high-density lipoprotein 
cholesterol, respectively; FFA = free fatty acids; LPL = lipoprotein lipase; HL = hepatic lipase; CETP = cho-
lesteryl ester transfer protein; oxLDL Ab = autoantibodies to epitopes of oxidized LDL. *P ≤ 0.05 compared 
to the early group (chi-square test and ANOVA with post hoc Duncan test).
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CETP in the FP and in the TAG peak period did not 
differ among groups (Table 1). However, in the early and 
late responders, CETP activity increased significantly from 
baseline to TAG peak period after the meal, but not in the 
biphasic groups (Figure 2C). 
Univariate linear regression analysis was performed to 
test the associations of metabolic and clinical parameters 
with mean cIMT, FP oxLDL Ab and TAG peak oxLDL Ab in 
the early and late groups (Table 2). 
In the early group, we observed significant associations 
of HL, AUIC TAG, AUIC VLDL cholesterol, and FP insulin 
(negative) and FP LPL (positive) with TAG peak oxLDL Ab, 
suggesting the main regulators of this biomarker. No asso-
ciations were observed with FP oxLDL Ab or mean cIMT. 
In the late group, the mean cIMT was positively as-
sociated with cholesterol (FP, time 2-8 h and AUC), TAG 
(FP, time 2-8 h and AUC), LDL cholesterol (FP, time 2-8 h 
and AUC) and VLDL cholesterol (FP, time 2-8 h and AUC). 
FP oxLDL Ab was positively associated with FFA 2 h and 
negatively associated with male gender, while the TAG 
peak oxLDL Ab in the late group was positively associated 
with AUIC cholesterol and AUIC FFA (Table 2). These as-
sociations suggest that lipids and autoantibodies against 
epitopes of oxidized LDL may exert an important effect on 
early atherosclerosis.
Multivariate analysis was then performed to confirm the 
associations with mean cIMT and oxLDL Ab (Table 3). In the 
early group, mean cIMT was positively explained by male 
gender and age, as described earlier, while in the late group 
cholesterol at the 6th hour was the cIMT regulator. In the 
late group the FP oxLDL Ab showed positive associations 
with FFA 2 h but negative associations with CETP at the 
4th hour, indicating the anti-oxidant role of CETP. 
Regarding the TAG peak oxLDL Ab, the early group 
showed positive associations with FP LPL and inverse 
associations with HL, while in the late group only AUIC 
cholesterol was positively associated. These lipases have 
ambiguous roles in atherogenesis (22,23).
Analysis of ApoE polymorphisms (N = 44) as determi-
nants of postalimentary lipemia showed that 14, 57, and 29% 
of the subjects presented ε2, ε3, and ε4 alleles, respectively. 
The distribution among apolipoprotein E genotypes was 
similar among all responders (P = 0.667). 
Discussion
The variations of lipids and lipoproteins in response to 
a fat meal were measured in order to detect associations 
with clinical and circulating atherosclerosis biomarkers. 
A phenomenon of fat carry-over from a previous meal 
to the postalimentary period of the subsequent meal has 
been described by several investigators (24) to explain the 
Figure 2. Postalimentary plasma free fatty acids (FFA), insulin and cholesteryl ester transfer protein (CETP) after a standardized meal. 
Data are reported as means ± SEM. N = minimum to maximum number of subjects with parameters determined. Wilcoxon and ANOVA 
with post hoc Duncan tests. A, FFA: all individuals [N = 54 subjects in the fasting period (FP), 4th and 8th hours; N = 52 at the 2nd 
hour and N = 51 at the 6th hour], 1P ≤ 0.008, FFA decreased from baseline to the 2nd and 4th hours, and increased to the 8th hour; 
early responders (N = 37 subjects in the FP and at the 4th and 8th hours; N = 35 at 2nd hour and N = 34 at 6th hour), 2P ≤ 0.045, 
FFA increased from baseline to the 8th hour; late responders (N = 17, all times), 3P ≤ 0.04, FFA decreased from baseline to the 2nd 
hour, 4P ≤ 0.005 to the 4th hour, and 5P ≤ 0.012 FFA increased to the 8th hour; early responders: 6P ≤ 0.00001 at the 4th hour higher 
than late and biphasic responders (N = 7, all times). B, Insulin: 1P ≤ 0.00001, 2P ≤ 0.00001, 3P ≤ 0.0009, 4P ≤ 0.018, respectively, in 
all individuals (N = 47 in FP and N = 45 in TAG peak), early responders (N = 31 in FP and N = 29 in TAG peak), late responders (N = 
16 in FP and TAG peak), and biphasic responders (N = 7 in FP and TAG peak), insulin increased from baseline to the 4th hour; early 
responders: 5P ≤ 0.00001, higher peak than in late and biphasic responders. C, CETP: in all individuals (N = 54 subjects in FP and 
N = 48 in TAG peak), early responders (N = 37 in FP and N = 33 in TAG peak) and late responders (N = 17 in FP and N = 15 in TAG 
peak), CETP increased from baseline to the 4th hour: 1P ≤ 0.0003, 2P ≤ 0.002, 3P ≤ 0.044, respectively (Wilcoxon test). Biphasic (N = 
7 subjects in FP and TAG peak): results not significant at 4th hour.
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behavior of late and biphasic responders (Figure 1; Table 1) 
These chylomicrons might be either stored in enterocytes 
or in the lymphatic vessels (25). Since in the present study 
the biphasic participants had fasted for 12 h before the liquid 
meal, it is not likely that they had stored chylomicrons from 
a previous meal, but rather that chylomicrons were formed 
following the more recent ingestion. The second peak at 
the 6th hour could be explained by increased VLDL pro-
duction and competition for clearance with chylomicrons in 
the postalimentary period (26). The extension of TAG-rich 
lipoprotein residence times in contrast to early responders 
can generate substrate availability for oxidation of VLDL 
and LDL, thereby inducing a local inflammatory stimulus, 
generation of autoantibodies to LDL epitopes and plaque 
formation in the artery wall (27).
Late and biphasic responders presented lower fasting 
and TAG peak plasma HDL cholesterol (16%) compared to 
early responders (Table 1). Since HDL has several effects on 
the inhibition of atherogenesis, such as a role in reverse cho-
lesterol transport, acting as an antioxidant, a profibrinolytic 
or an antithrombogenic agent, its reduction is implicated in 
an increase in the risk of atherosclerosis (28). 
On the other hand, there is also an inverse relationship 
between circulating HDL cholesterol and TAG, but in this 
study fasting triacylglycerol levels did not differ between 
the three groups. This was surprising because fasting 
hypertriglyceridemia has been identified as the strongest 
determinant of postprandial lipemia (29). It has been 
reported that subjects with reduced fasting plasma HDL 
cholesterol levels are characterized by increased postali-
mentary lipemia. Therefore, the described observation of 
the postalimentary state phenotypes could possibly be an 
HDL effect as well as an effect of response time. 
Cholesteryl ester transfer protein is a plasma lipid 
transfer protein that has the ability to transfer cholesteryl 
esters from HDL to apolipoprotein B-containing lipoproteins 
playing an important role in reverse cholesterol transport. 
The absent CETP response in biphasic individuals during 
the postalimentary period would favor the accumulation 
of TAG-rich lipoproteins. When CETP activity is reduced, 
the transfer of lecithin:cholesterol acyltransferase-derived 
cholesteryl esters from HDL to other lipoprotein fractions 
is reduced and as a result the total core lipid content and 
the particle surface of HDL increase (30). In addition, the 
clearance of TAG-rich lipoproteins is reduced. This agrees 
with the higher TAG at the 6th and 8th hours after the meal 
in the late group. The mechanism(s) underlying the reduction 
of CETP activity in late responders is unknown but could 
be secondary to chemical modifications of postalimentary 
HDL particles. 
During the TAG peak period the insulin concentration 
was much lower (-77%) in late responders than in the early 
group (Table 1; Figure 2). We propose that the diminished 
response is a metabolic consequence of previous meals due 
to a chronic and regular proximity between them and their 
Table 2. Univariate linear regression analysis for subclinical ca-
rotid atherosclerosis and antibodies against oxidized LDL in early 
and late responders.
Beta (SE) P R2
Early group (N = 26)
TAG peak oxLDL Ab
FP HL -0.43 (0.17) 0.021 0.2015
FP LPL 0.47 (0.16) 0.006 0.2767
AUIC TAG -0.37 (0.16) 0.028 0.1864
AUIC VLDL-C -0.37 (0.16) 0.028 0.1861
FP insulin -0.40 (0.17) 0.025 0.1914
Late group§ (N = 14)
Mean cIMT
Gender (male) 2.94 (2.07) 0.184 0.1548
Age (years) 0.34 (0.23) 0.161 0.1701
FP cholesterol 0.57 (0.17) 0.008 0.4908
Cholesterol 2 h 0.59 (0.19) 0.011 0.4621
Cholesterol 4 h 0.59 (0.18) 0.007 0.5035
Cholesterol 6 h 0.69 (0.15) <0.001 0.6676
Cholesterol 8 h 0.63 (0.18) 0.005 0.5240
AUC cholesterol 0.60 (0.18) 0.006 0.5096
FP TAG 0.58 (0.17) 0.006 0.5057
TAG 2 h 0.59 (0.18) 0.008 0.4828
TAG 4 h 0.51 (0.20) 0.028 0.3696
TAG 6 h 0.57 (0.17) 0.006 0.5085
TAG 8 h 0.58 (0.19) 0.012 0.4546
AUC TAG 0.60 (0.17) 0.005 0.5277
FP LDL-C 0.62 (0.16) 0.003 0.5708
LDL-C 2 h 0.61 (0.17) 0.004 0.5485
LDL-C 4 h 0.56 (0.18) 0.009 0.4821
LDL-C 6 h 0.58 (0.17) 0.007 0.5013
LDL-C 8 h 0.57 (0.18) 0.008 0.4839
AUC LDL-C 0.57 (0.18) 0.008 0.4889
FP VLDL-C 0.59 (0.18) 0.007 0.5026
VLDL-C 2 h 0.59 (0.18) 0.007 0.4952
VLDL-C 4 h 0.53 (0.20) 0.020 0.4023
VLDL-C 6 h 0.57 (0.17) 0.006 0.5085
VLDL-C 8 h 0.61 (0.19) 0.008 0.4919
AUC VLDL-C 0.61 (0.17) 0.004 0.5453
FP oxLDL Ab
Gender (male) -4.67 (1.93) 0.032 0.3282
FFA 2 h 0.71 (0.16) <0.001 0.6140
TAG peak oxLDL Ab
AUIC cholesterol 0.58 (0.21) 0.016 0.3939
AUIC FFA 0.58 (0.21) 0.018 0.3864
Beta (SE) = value of the slope in the regression line (standard error); 
R2 = coefficient of determination. For explanation of early and late 
groups, see legend to Table 1. FP = fasting period; oxLDL Ab = au-
toantibodies to epitopes of oxidized LDL; TAG = triacylglycerol; cIMT 
= carotid intima-media thickness; HL = hepatic lipase; LPL = lipopro-
tein lipase; AUIC = areas under the incremental curves; VLDL-C and 
LDL-C = very low-density and low-density lipoprotein cholesterol, 
respectively; AUC = areas under the curve; FFA = free fatty acids. 
§Late and biphasic responders were pooled.
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synergistic effects. The response profile is 
more similar to the one of the fasting period. 
In accordance with this hypothesis no TAG 
peaks were observed at the 4th hour and 
fasting LPL activity was higher (26%) in 
late responders, reflecting a previous meal 
effect. Furthermore, the similar TAG in the 
early and late groups reflects increased 
lipolysis in the latter group. 
In early responders, FFA concentrations 
increased up to the 8th hour after the meal 
(Table 1; Figure 2). In late and biphasic 
responders, despite the reduced insulin 
concentrations, a paradoxical 43% decrease 
in FFA concentration was observed at the 
4th hour and an increase again up to the 
8th hour. The decrease in FFA is suggestive 
of a stimulated tissue uptake or a hyper-
responsiveness to insulin. In addition, a de-
creased postalimentary lipolysis mediated by 
lipoprotein lipase could be ruled out, although 
the lipase activities were not measured in 
the postalimentary period. Moreover, the 
decreased insulin concentration observed in 
these late responders in the postalimentary 
period could favor TAG lipolysis in the adi-
pose tissue and a consequent increase in 
plasma FFA concentration; consequently, an increased liver 
production of VLDL with a decreased lipolysis rate of TAG-rich 
lipoproteins would occur. This agrees with the observations of 
a higher 6th- and 8th-hour TAG in the late group. 
Subclinical carotid atherosclerosis has been related to 
age, gender, smoking, high cholesterol and LDL cholesterol, 
triglycerides, and postalimentary lipemia (31).
In the late group, the univariate positive associations with 
mean cIMT with age, gender and all lipid profile components 
and their respective AUC at all times, with the exception of 
HDL cholesterol, suggest the presence of an atherogenic 
lipid profile in the postalimentary period. Corroborating this 
fact, we observed positive associations in the FP of oxLDL 
Ab with FFA at 2 h and male gender, and in the TAG peak 
with cholesterol and FFA AUIC.
In the early group, TAG peak oxLDL Ab was inversely 
related to TAG and VLDL cholesterol AUIC and insulin, 
suggesting physiologic response patterns. Its negative as-
sociation with HL and positive association with LPL indicate 
opposite roles of these lipases in the generation of post-
alimentary oxidized lipids, discussed with the subsequent 
multivariate analysis.
In the definitive multivariate analysis, as expected, the 
early responders’ mean cIMT was explained by gender 
(males) and age and in late responders by cholesterol 
levels at the 6th hour, 146 ± 32 mg/dL (data not shown), 
values very similar to the TAG peak cholesterol (149 ± 30 
mg/dL). 
Interestingly, in early responders LPL and HL regulated 
the titers of antibodies against oxidized LDL in a positive 
and negative manner, respectively. 
The increased LPL activity implies a higher generation of 
FFA, and it is well known that different fatty acids liberated 
during lipolysis may have different actions on inflammation. 
Omega-6 polyunsaturated fatty acids promote inflammation, 
whereas the omega-3 family has anti-inflammatory proper-
ties such as inhibiting cytokine production in leukocytes 
(32), decreasing NF-κB activation and IL-1, IL-6, and TNF-α 
mRNA expression in different experimental models (33). 
The positive regulation of oxLDL Ab by LPL agrees with a 
publication that attributed an inflammatory function to LPL 
(22). Another interesting fact is that the macrophage LPL 
locally releases fatty acids that may serve as an energy 
source, but is also a potential pro-inflammatory stimulus 
for these cells by the formation of lipid droplets, inducing 
endoplasmic reticulum stress (34,35).
Hepatic lipase has dual functions as a triglyceride hy-
drolase and ligand/bridging factor for receptor-mediated 
lipoprotein uptake. Consistently, human and animal studies 
support antiatherogenic (36) and pro-atherogenic roles for 
hepatic lipase since genetically low or absent HL activity can 
be associated with increased CAD risk (23). The genetic 
variation of the HL gene is associated with TAG and lipo-
proteins containing elevated apoB levels in humans (37). 
The negative association with HL agrees with the increase 
in these lipoprotein levels and possibly with the higher 
generation of oxidized LDL and its autoantibodies.
Table 3. Relationships of early carotid atherosclerosis and antibodies against 
oxidized LDL with anthropometric and metabolic parameters in early and late re-
sponders.
Beta (SE) P Partial R2
Early group - Mean cIMT (N = 26)
Gender (male) 8.35 (3.00) 0.011 0.1661
Age (years) 0.37 (0.17) 0.044 0.1375
Early group - TAG peak oxLDL Ab (N = 26)
FP LPL (nmol FFA·mL-1·h-1) 0.42 (0.15) 0.008 0.2767
FP HL (nmol FFA·mL-1·h-1) -0.36 (0.15) 0.029 0.1378
Late group§ - Mean cIMT (N = 12)
Cholesterol 6 h 0.75 (0.15) <0.001 0.7113
Late group§ - FP oxLDL Ab (N = 14)
FFA 2 h (nM) 0.68 (0.14) <0.001 0.6140
CETP 4 h (%) -0.35 (0.16) 0.048 0.1199
Late group§ - TAG peak oxLDL Ab (N = 14)
AUIC cholesterol 0.58 (0.21) 0.016 0.3939
Beta (SE) = value of the slope in the regression line (standard error); R2 = coefficient 
of determination. For explanation of early and late groups, see legend to Table 1. 
FP = fasting period; oxLDL Ab = autoantibodies to epitopes of oxidized LDL; FFA = 
free fatty acids; CETP = cholesteryl ester transfer protein; LPL = lipoprotein lipase; 
HL = hepatic lipase; AUIC = areas under the incremental curves. §Late and biphasic 
responders were pooled.
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In late responders, oxLDL Ab was positively regulated 
by FFA and negatively regulated by CETP. As discussed 
before, the FFA released in lipolysis can act as an inflamma-
tory stimulus, indirectly explaining the positive association 
with the antibodies against oxLDL. 
In animal models of acute inflammation, CETP was 
shown to act as a first line of defense by reducing the exac-
erbated production of TNF-α and IL-6, both pro-inflammatory 
mediators (38). CETP can also decrease the macrophage 
cholesteryl ester content and decrease the circulating 
oxidized LDL (39); so, the negative association of CETP 
activity with oxLDL Ab during the fasting period reinforces 
a pro-atherogenic character of CETP reduction, even after 
the changes caused by the postprandial state. 
This study is the first to provide a characterization of a 
possible postalimentary insulin resistance state combined 
with a reduced CETP response - and possible decreased 
reverse cholesterol transport - exclusive to late responders, 
and the identification of the regulators of postalimentary 
atherogenicity, although the number of individuals studied 
was limited and no mechanisms were studied in depth. 
The data presented in this study suggest that in asymp-
tomatic adults a fat diet can produce higher or lower potential 
atherogenic changes depending on the individual response 
phenotype. These results call attention to the fact that in 
primary atherosclerosis prevention individuals presenting 
predisposing and risk factors for atherosclerosis (such as 
metabolic syndrome, obesity, sedentariness, smoking, and 
hypertension) an increased postprandial response would 
occur, leading to further atherosclerotic repercussions.
Further research is required to determine the meta-
bolic mechanisms described in the different postalimentary 
phenotypes observed in the present study, as well as in 
different pathological states, as currently investigated in 
our laboratory.
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